Volitionrx (VNRX) Equity Average (2012 - 2025)

Volitionrx has reported Equity Average for 10 years, with the latest figure at -$35.8 million in Q4 2025.

• For the quarter ending Q4 2025, Equity Average fell 50.46% year-over-year to -$35.8 million; the trailing twelve-month figure through Dec 2025 stood at -$35.8 million (down 50.46% YoY), and the FY2025 full-year result was -$30.3 million, down 79.95% from the prior year.
• Equity Average for Q4 2025 stood at -$35.8 million, down from -$34.5 million in the prior quarter.
• The five-year high for Equity Average was $28.9 million in Q2 2021, with the low at -$35.8 million in Q4 2025.
• Historically, Equity Average has averaged -$4.6 million across 5 years, with a median of -$1.6 million in 2022.
• Annual changes were most pronounced in 2021 — Equity Average soared 107.52% — and 2023, when it sank 3927.22%.
• Volitionrx's Equity Average stood at $19.5 million in 2021, then tumbled by 100.74% to -$143567.0 in 2022, then slumped by 3927.22% to -$5.8 million in 2023, then plunged by 311.19% to -$23.8 million in 2024, then plunged by 50.46% to -$35.8 million in 2025.
• The last three Equity Average figures came in at -$35.8 million (Q4 2025), -$34.5 million (Q3 2025), and -$31.1 million (Q2 2025), per Business Quant data.